Large-scale testing (Phase 3)Study completedNCT03575052
What this trial is testing
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Who this might be right for
Neuropsychiatric Symptoms Related to Neurodegenerative Disease
ACADIA Pharmaceuticals Inc. 784